Tag: CheckMate 012
CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in...
By Neal Ready, MD, PhD
Posted: February 12, 2020
Programmed death receptor (PD-1) checkpoint monoclonal antibody therapy has proven a major advancement in the management of...